Precision in the pancreas: New test transforms hereditary pancreatitis diagnosis and care
Business Announcement
Updates every hour. Last Updated: 22-Dec-2025 12:11 ET (22-Dec-2025 17:11 GMT/UTC)
Polycyclic aromatic hydrocarbons (PAHs) are carcinogenic compounds introduced in food due to cooking methods such as smoking, grilling, and frying. Recently, researchers from Seoul National University of Science and Technology have leveraged a new method called QuEChERS-GC-MS to extract and detect PAHs in common food items, finding the highest levels in soybean oil, followed by duck meat and canola oil.
Researchers have discovered a promising new approach to lung cancer treatment. A small molecule called AVJ16 selectively blocks the cancer-driving protein IGF2BP1, halting tumor growth in preclinical studies and killing cancer cells in patient-derived models—while leaving healthy cells unharmed. The findings could pave the way for a new generation of targeted therapies.
An international research group led by The University of Osaka has developed scODIN, a novel computational tool to classify cell types from single-cell RNA sequencing (scRNA-seq) data. Existing methods struggle to balance speed and accuracy, often misclassifying rare or transitional cells. scODIN overcomes this limitation by combining a hierarchical classification system (Tier system) with k-nearest neighbor inference. This approach allows for the rapid and accurate classification of large datasets, processing 650,000 cells in just six minutes. The tool's improved accuracy stems from its ability to identify cells at varying levels of detail, recognize intermediate phenotypes through double labeling, and recover cells affected by dropout events. scODIN promises to accelerate biomedical discoveries by enabling more precise and efficient analysis of complex biological processes and disease mechanisms.
Death rates from diseases such as cancer, heart disease and stroke declined in four out of five countries around the world in the decade leading up to the COVID-19 pandemic, but progress has slowed compared to the previous decade.
Scientists at St. Jude Children’s Research Hospital explored how mutations in mitochondrial DNA contribute to cancer, the extent of their impact, and when and how they become a factor.
The rapid rise of adults taking GLP-1RA medications (e.g., Wegovy, Ozempic, Mounjaro) in the U.S. (16 million and counting) and around the world has been accompanied by a slew of the drugs’ proclaimed health benefits. Weight loss is a common (and extremely popular) side effect, making GLP-1RAs some of the most exciting weapons in the arsenal for battling the obesity epidemic. Loss of unhealthy visceral fat and improved blood sugar control are just two of the downstream effects of this weight loss, which, in turn, promise their own health benefits.
But what do we really know about the long-term impacts of GLP-1RA medications? Researchers caution us not to get ahead of ourselves when it comes to the logical, though still theoretical, possibilities of how these drugs may influence related health conditions such as cancer.
New research published in Immunity by researchers at the University of Pittsburgh found that, in mice, the toxic tumor environment causes mitochondria to generate reactive oxygen species (ROS) that travel to the nucleus and damage telomeres, driving T cells to a dysfunctional state. By preventing damage to telomeres via a targeted antioxidant, scientists hope to rescue T cell function, opening the door to novel therapies to improve the effectiveness of cancer immunotherapies.